MoneyWorks4Me

Bliss GVS Pharma informs about disclosure

26 Jun 2025 Evaluate
Bliss GVS Pharma has informed that it enclosed disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Gagan Harsh Sharma & PACs.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1752.45
Dr. Reddys Labs. 1171.50
Cipla 1292.50
Lupin 1952.90
Zydus Lifesciences 1111.75
View more..